Cantor Fitzgerald Reiterates Neutral on Pfizer, Maintains $27 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 76.9%

Neg 0% Neu 76.9% Pos 0%

Cantor Fitzgerald analyst Carter Gould reiterates Pfizer (NYSE:PFE) with a Neutral and maintains $27 price target.

Comments

No comments yet. Be the first!